Related references
Note: Only part of the references are listed.Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies
Louisa K. James et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
From Allergen Genes to Allergy Vaccines
Rudolf Valenta et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Recombinant allergens. For routine use or still only science?
P. Schmid-Grendelmeier
HAUTARZT (2010)
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet
Hans de Groot et al.
ALLERGY (2009)
Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen
I. Stelmach et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy
Eva Netterlid et al.
CONTACT DERMATITIS (2009)
Safety of sublingual immunotherapy started during the pollen season
Renato Ariano et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Molecular composition and biological activity of commercial birch pollen allergen extracts
M. Focke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Comparative Study of Cluster and Conventional Immunotherapy Schedules with Dermatophagoides pteronyssinus in the Treatment of Persistent Allergic Rhinitis
Luo Zhang et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
Albrecht Bufe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
Ulrich Wahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
The safety of sublingual immunotherapy with one or more allergens in adults
C. Lombardi et al.
ALLERGY (2008)
Results of the patient voice allergy survey. Impact of allergic rhinitis in Europe
S. Nasser et al.
ALLERGY (2008)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet et al.
ALLERGY (2008)
Economic evaluation of sublingual vs subcutaneous allergen immunotherapy
Jitka Pokladnikova et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy
Noel Rodriguez-Perez et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Heterogeneity of commercial timothy grass pollen extracts
M. Focke et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
Gabrielle Pauli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years
Ronald Dahl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
BSACI guidelines for the management of allergic and non-allergic rhinitis
G. K. Scadding et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
Alain Didier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Cost-effectiveness of GRAZAX® for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe
G. W. Canonica et al.
RESPIRATORY MEDICINE (2007)
Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children
Maria Dolores Ibanez et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2007)
Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts
Thomas J. Grier et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy
M. A. Calderon et al.
ALLERGY (2007)
Early and late phase asthmatic response in lower airways of cat-allergic asthmatic patients -: a comparison between experimental and environmental allergen challenge
M. B. Arvidsson et al.
ALLERGY (2007)
Cost-effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis -: a Northern European perspective
C. Bachert et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients
Maurizio Marogna et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Immunoregulation by targeting T cells in the treatment of allergy and asthma
Mark Larche
CURRENT OPINION IN IMMUNOLOGY (2006)
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
Peter S. Creticos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
Ronald Dahl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Standardization of allergen-specific immunotherapy vaccines
Michael D. Spangfort et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis
AJ Frew et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Standards for practical allergen-specific immunotherapy
E. Alvarez-Cuesta et al.
ALLERGY (2006)
Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes
F Karamloo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Allergen-specific immunotherapy with recombinant grass pollen allergens
M Jutel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid
CJ Corrigan et al.
ALLERGY (2005)
Monophosphoryl lipid A (MPL®) promotes allergen-induced immune deviation in favour of Th1 responses
F Puggioni et al.
ALLERGY (2005)
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy
F Kussebi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite
P Maestrelli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity
KT Nouri-Aria et al.
JOURNAL OF IMMUNOLOGY (2004)
Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells
LK Wilcock et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut
X Bucher et al.
ALLERGY (2004)
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract
A Nanda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis
T Bowen et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2004)
Molecular mechanisms in allergy and clinical immunology
SJ Till et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Prevalence and rate of diagnosis of allergic rhinitis in Europe
V Bauchau et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Food allergy to apple and specific immunotherapy with birch pollen
KS Hansen et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2004)
Vaccination with genetically engineered allergens prevents progression of allergic disease
V Niederberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis
H Smith et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis
E Novembre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
A survey on the management of pollen-food allergy syndrome in allergy practices
SH Ma et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites
F Marcucci et al.
ALLERGY (2003)
Management of rhinitis and asthma in pregnancy
MS Blaiss
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)
Immunomodulation during sublingual therapy in allergic children
F Ippoliti et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2003)
Noninjection routes for immunotherapy
GW Canonica et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
From allergen structure to new forms of allergen-specific immunotherapy
R Valenta et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)
C Möller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
J Kuehr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.
GB Pajno et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2001)
A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
KJ Drachenberg et al.
ALLERGY (2001)
Share Paper
